Left Ventricular Outflow Tract Obstruction (LVOTO) is a dynamic and often underrecognized cause of hemodynamic instability in critically ill patients. While more common in those with anatomical features like septal hypertrophy or hypertrophic cardiomyopathy, it can also occur in hyperdynamic states such as septic shock, stress-induced cardiomyopathy, acute hemorrhage/hypovolemia, or after excessive inotrope administration—even in patients without any anatomical predisposition. Its clinical presentation is often subtle and can mimic other causes of shock, making early recognition essential. A high index of suspicion and a systematic echocardiographic approach are crucial for early diagnosis, identifying features such as hypercontractility, systolic anterior motion of the mitral valve, LVOT narrowing, and flow acceleration on Color Doppler Imaging. Doppler imaging—particularly color flow mapping and continuous-wave (CW)—is vital for confirming and localizing the obstruction. A “dagger-shaped”, late-peaking waveform of CW Doppler is pathognomonic. In cases with limited acoustic windows, transesophageal echocardiography represents an alternative.

Management focuses on reversing underlying triggers and optimizing myocardial loading conditions. Discontinuation of pro-obstructive agents ( e.g. , inotropes), fluid resuscitation to enhance preload, and afterload augmentation using pure alpha-agonists ( e.g. , phenylephrine) can be very effective in further decreasing the LVOT pressure gradient. Selective use of short-acting beta-blockers might be considered to reduce contractility and heart rate. Lowering positive end-expiratory pressure (PEEP) may also benefit preload-dependent patients.

We propose the “LVOTO bundle” to facilitate the treatment by summarizing key therapeutic steps. Timely and bundled-targeted interventions are vital to reverse this potentially life-threatening condition and improve outcomes in critically ill patients.